| 1. |
- Forsell, Erik, et al.
(författare)
-
Internet delivered cognitive behavior therapy for antenatal depression : A randomised controlled trial
- 2017
-
Ingår i: Journal of Affective Disorders. - Amsterdam, Netherlands : Elsevier. - 0165-0327 .- 1573-2517. ; 221, s. 56-64
-
Tidskriftsartikel (refereegranskat)abstract
- Major depression occurs in 5-10% of pregnancies and is associated with many negative effects for mother and child, yet treatment options are scarce. To our knowledge, this is the first published randomised controlled trial on Internet delivered Cognitive Behavior Therapy (ICBT) for this group.Objective: To test the efficacy of a pregnancy adapted version of an existing 10-week ICBT-program for depression as well as assessing acceptability and adherence.Design: Randomised controlled trial.Setting: Online and telephone.Population or sample: Self-referred pregnant women (gestational week 10-28 at intake) currently suffering from major depressive disorder.Methods: 42 pregnant women (gestational week 12-28) with major depression were randomised to either treatment as usual (TAU) provided at their antenatal clinic or to ICBT as an add-on to usual care.Main outcome measures: The primary outcome was depressive symptoms measured with the Montgomery-Asberg depression rating scale-self report (MADRS-S). The Edinburgh Postnatal Depression Scale and measures of anxiety and sleep were used. Credibility, satisfaction, adherence and utilization were also assessed.Results: The ICBT group had significantly lower levels of depressive symptoms post treatment (p < 0.001, Hedges g = 1.21) and were more likely to be responders (i.e. achieve a statistically reliable improvement) (RR = 0.36; p = 0.004). Measures of treatment credibility, satisfaction, utilization, and adherence were comparable to implemented ICBT for depression.Limitations: Small sample size and no long-term evaluation.Conclusion: Pregnancy adapted ICBT for antenatal depression is feasible, acceptable and efficacious. These results need to be replicated in larger trials to validate these promising findings.
|
|
| 2. |
- Heinonen, Essi, et al.
(författare)
-
MAGDALENA : study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero
- 2018
-
Ingår i: BMJ Open. - : BMJ Publishing Group Ltd. - 2044-6055. ; 8:8
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction Ten per cent of all pregnant women are depressed. Standard therapy of pregnant women with moderate depression is selective serotonin reuptakeinhibitors (SSRI). Observational studies on neurodevelopment after fetal SSRI exposure show conflicting results. Our primary objective is to compare the cognitive development in children exposed to sertraline and maternal depression with those exposed to maternal depression and placebo in utero. We hypothesise that there is a significant neurodevelopmental difference between the groups. As a secondary objective, we study the add-on effect of sertraline to internet-based cognitive behavioural therapy (ICBT) to treat moderate depression during pregnancy. Methods and analysis MAGDALENA is a randomised, placebo-controlled, double-blinded trial in Stockholm Healthcare Region with 2.3 million inhabitants. The women are recruited in weeks 9-21 of pregnancy either through Antenatal Health Clinics or through social media. They are to be diagnosed with moderate depression without ongoing antidepressive therapy or any serious comorbidity. The women in the intervention arm receive sertraline combined with a 12-week period of ICBT; the control arm is treated with placebo and ICBT. We assess the cognitive development in the offspring at the age of 2 years using Bayley Scales of Infant and Toddler Development, third edition (BSID-III). We aim at recruiting 200 women, 100 women in each treatment arm, to ensure statistical power to detect a clinically relevant difference between the groups. Ethics and dissemination This randomised trial will provide long-sought evidence about the effects of SSRI and maternal depression during pregnancy on the neurodevelopment in the offspring. The study is approved by the Regional Ethical Review Board at Karolinska Institutet in Stockholm and the Swedish Medical Products Agency. It is registered with the European Clinical Trials Database (EudraCT), Number: 2013-004444-31. Results will be disseminated at scientific conferences, published in peer-reviewed journals and made available to the public.
|
|
| 3. |
- Lindqvist, Pelle G, et al.
(författare)
-
[Vasa praevia test can save lives in Swedish maternity wards]
- 2011
-
Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 108:4, s. 150-151
-
Tidskriftsartikel (refereegranskat)abstract
- Vasa praevia bleeding is a rare (1:4000) obstetric complication. It is associated with a high risk of fetal death (30% to 70%), but is harmless for the mother. After an investigation of the fatal outcome of a case of vasa praevia that was judged to have been avoidable, the Swedish National Board of Health and Welfare determined there is methodology available for the diagnosis of fetal (i.e., vasa praevia) bleeding. They concluded that such “methodology should be introduced in all Swedish maternity wards” and subsequently contacted the Swedish Association of Obstetrics and Gynecology (SFOG) seeking national guidelines in this matter.
|
|
| 4. |
- Nasiell, Josefine
(författare)
-
Expression and regulation of vasoactive substances, sex steroids and their receptors in placenta during normal pregnancy and preeclampsia
- 2002
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Despite intense studies preeclampsia remains enigmatic and a major cause of maternal and fetal morbidity and mortality. It is now widely accepted that the placenta has a central role in preeclampsia; delivery of the placenta is the only known cure. Its manifestations are considered secondary to inadequate trophoblast invasion of the uterine spiral arteries, which leads to placenta] ischemia and further to the devastating multisystem disorder of the mother and often the fetus. The syndrome is characterised by increased vasoconstriction and endothelial dysfunction. Several biochemical changes in the placenta are evident. The nitric oxide (NO) system as well as the sex steroid hormones, estrogen and progesterone have been implicated in the aetiology of preeclampsia. However the role and the regulation of these substances is still not clear. The aim of the present thesis was to study some of the genes expressed in the placenta that could be involved in the pathophysiology of preeclampsia and/or intrauterine growth restriction (IUGR). Consecutive biopsies of fresh placentas were collected from normal and preeclampsia-complicated placentas. A placental tissue in vitro model was set up for experiments. For mRNA studies of endothelin-1, c-fos and c-jun, the progesterone receptor (PR) and the estrogen receptor (ER) we used a solution hybridisation method, which showed elevated expression of ET-1 and c-fos in IUGR placentas. The c-jun mRNA was significantly higher in the groups with preeclampsia and/or IUGR compared to controls. Furthermore, in situ hybridisation of the PR demonstrated it to be localised in endothelium, in fetal lymphocytes of placental capillaries and occasionally in matemal mononuclear cells. The PR protein content in the different groups showed that the level was decreased in severe preeclampsia but increased in mild preeclampsia compared to healthy controls. Measurement of progesterone content in placental tissue explants showed that addition of the antiprogestin RU-486 decreased the level of progesterone in the healthy placentas, whereas no such decrease was seen in the placentas from patients with preeclampsia after RU-486 treatment. Furthermore the effect of the antiestrogen, ICI 182,780 was different in placentas from control and preeclamptic patients. eNOS immunosignal recorded by immunohistochemistry and confocal microscopy was significantly increased in the syncytiotrophoblasts of healthy placentas after ICI treatment but decreased in the preeclampsia placentas. We suggest that an inadequate supply of progesterone, a deficiency in the mechanism of action of progesterone and/or an altered balance between the sex steroids produced by the placenta could influence not only the immune system but also the NO pathway and hereby contribute to several changes characteristic of preeclampsia.
|
|
| 5. |
- Vinnars, Marie-Therese, et al.
(författare)
-
Association between cerebral palsy and microscopically verified placental infarction in extremely preterm infants
- 2015
-
Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - : Wiley. - 0001-6349 .- 1600-0412. ; 94:9, s. 976-982
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: Previously, cerebral palsy has been associated with placental infarctions diagnosed macroscopically by midwifes. However, the risk of misclassification of infarctionsis is high without a histological verification. Therefore, the objective of this study was to study placental histopathology in relation to developmental outcome at 2.5 years corrected age in a population born extremely preterm.Material and methods: A prospective cohort study was carried out at Karolinska University Hospital, Stockholm, Sweden on a population of 139 live born infants delivered <27 gestational weeks during 2004–2007. A senior perinatal pathologist, who was blinded to outcome data, evaluated all placental slides microscopically. Neuromotor and sensory functions of the children were evaluated. Bayley Scales of Infant and Toddler Development-III (Bayley-III) were used to assess development at corrected age 2.5 years. The outcome data were evaluated without reference to obstetrical and pathology data. The primary outcome measure was neurological and developmental status at 2.5 years of corrected age. This was measured as diagnosis of cerebral palsy, visual impairment, hearing impairment as well as performance on Bayley-III scales evaluating cognitive, language and motor functions.Results: Two out of seven children with placental infarction were diagnosed with cerebral palsy compared with one child of 51 without placental infarction (p = 0.036). For developmental outcome according to Bayley-III at 2.5 years no statistically significant associations with placental pathology were found.Conclusion: A possible association between placental infarction, verified by microscopic examination, and cerebral palsy has been identified in this extremely preterm population.
|
|
| 6. |
- Vinnars, Marie-Therese, et al.
(författare)
-
Association between placental pathology and neonatal outcome in preeclampsia: a large cohort study
- 2014
-
Ingår i: Hypertension in Pregnancy. - : Informa Healthcare. - 1064-1955 .- 1525-6065. ; 33:2, s. 145-158
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To study associations between placental histopathology and neonatal outcome in preeclampsia (PE).Study design: The cohort consisted of 544 singleton pregnancies complicated by PE and managed at Karolinska University Hospital, Stockholm, Sweden during 2000–2009. Evaluation of placental histopathology was made by one senior perinatal pathologist, blinded to outcome. Clinical outcome was obtained from prospectively collected medical registry data and medical records. Main outcome measures were intrauterine fetal death, smallness for gestational age, admission to neonatal unit, major neonatal morbidity (defined as presence of intraventricular hemorrhage ≥grade 3, retinopathy of prematurity ≥grade 3, necrotizing enterocolitis, cystic periventricular leucomalacia and/or severe bronchopulmonary dysplasia) and neonatal mortality. Logistic regression analyses including gestational age were performed.Results: Abnormal placental weight, both low (adjusted odds ratio (OR) [95% confidence interval] 5.2 [1.1–24], p = 0.03) and high (adjusted OR 1048 [21–51 663], p < 0.001) for gestational age, was associated with major neonatal morbidity in preterm infants. Accelerated villous maturation was less prevalent in intrauterine fetal death pregnancies (adjusted OR 0.18 [0.04–0.77], p = 0.02). Decidual arteriopathy increased the odds for admission to neonatal care (adjusted OR 2.7 [1.1–6.5], p = 0.03). Infarction involving ≥5% of the placenta was associated with intrauterine fetal death and small for gestational age infants (adjusted OR’s 75 [5.5–1011], p = 0.001 and 3.2 [1.7–5.9], p < 0.001; respectively). No relations between histological variables and neonatal mortality could be found. Conclusion: Placental pathology in PE reflects adverse perinatal events and deviant placental weight predicts adverse neonatal outcome in preeclamptic women delivering preterm. Placental investigation without delay can contribute to neonatal risk assessment.
|
|
| 7. |
- Vinnars, Marie-Therese, et al.
(författare)
-
Placental pathology in relation to stillbirth and neonatal outcome in an extremely preterm population: a prospective cohort study
- 2015
-
Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - : Blackwell Publishing. - 0001-6349 .- 1600-0412. ; 94:6, s. 584-590
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To study associations between placental histopathology and stillbirth as well as neonatal outcome in a population born extremely preterm.Design: Prospective cohort study.Setting: Stockholm, Sweden.Population: 167 infants born <27 gestational weeks during 2004–2007.Methods: One senior perinatal pathologist, blinded to outcome data, evaluated all placental slides.Main outcome measures: Intrauterine fetal death, small-for-gestational age, major neonatal morbidity (intraventricular hemorrhage ≥grade 3, retinopathy of prematurity ≥grade 3, necrotizing enterocolitis, cystic periventricular leukomalacia or severe bronchopulmonary dysplasia) and neonatal mortality. Additional outcome variables were Apgar score at 5 min, sepsis, and treated patent ductus arteriosus.Results: Accelerated villous maturation was associated with a decreased risk for Apgar score <7 at 5 min (p = 0.041). Fetal thrombosis and low placental weight were associated with an increased risk for both intrauterine fetal death (p < 0.001 and p = 0.011, respectively) and small-for-gestational age (p < 0.001 and p < 0.001, respectively).Conclusion: Placental histology may have prognostic value as it appears to be associated with intrauterine fetal death, as well as with being small-for-gestational age and assignment of a low Apgar score at birth.
|
|
| 8. |
- Vinnars, Marie-Therese, et al.
(författare)
-
Placental pathology in smoking and non-smoking preeclamptic women
- 2015
-
Ingår i: The Journal of Maternal-Fetal & Neonatal Medicine. - : Informa Healthcare. - 1476-7058 .- 1476-4954. ; 29:5, s. 733-736
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To ascertain whether the protective effect of smoking during preeclampsia (PE) can be visualized in the placenta.Methods: The study cohort consisted of placentas (n = 523) from pregnancies complicated by PE, delivered at Karolinska University Hospital in Stockholm during the period 2000–2009. Of the women included in the study, 488 were non-smokers and 35 were smokers at first visit to maternity care. Outcome variables were placental infarctions and decidual arteriopathy.Results: Infarctions (affecting ≥5% of the placental tissue) were found in 15.6% of the placentas from non-smokers and in 25.7% of the placentas from smokers (OR 1.88: CI 0.84–4.16, p = 0.12). Decidual arteriopathy was found in 27.5% of the placentas from non-smokers and in 40.0% of the placentas from smokers (1.76: CI 0.87–3.56, p = 0.12). When diagnosed histopathologically, placental abruption was found in 15.4% among non-smokers and in 17.1% among smokers (1.14: CI 0.46–2.84, p = 0.98). Those differences did not show any statistical significance.Conclusion: No significant differences concerning placental infarctions, decidual arteriopathy or abruption were found between preeclamptic placentas from non-smokers compared to smokers.
|
|
| 9. |
- Vinnars, Marie-Therese, et al.
(författare)
-
Severe Preeclampsia With and Without HELLP Differ With Regard to Placental Pathology
- 2008
-
Ingår i: Hypertension. - : American Heart Association. - 0194-911X .- 1524-4563. ; 51:5, s. 1295-1299
-
Tidskriftsartikel (refereegranskat)abstract
- The aim of the present study was to evaluate the histopathology in placentas from patients with severe preeclampsia with and without hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. An additional aim was to compare the prevalence of infants born small for gestational age in the 2 groups. The study is retrospective and includes 178 women who have been diagnosed at the Karolinska University Hospital Huddinge or at the Free University Medical Center between 2000 and 2005 with severe preeclampsia. A total of 96 women had severe preeclampsia without signs of HELLP (preeclampsia group), whereas 82 fulfilled the criteria for having HELLP syndrome (HELLP group). Infarction (P=0.014), intervillous thrombosis (P<0.001), and abruption (P=0.002) were more common in the preeclampsia group than in the HELLP group. There was no statistically significant difference in the frequency of accelerated villous maturation (P=0.61), decidual arteriopathy (P=0.27), or chorioamnionitis (P=0.61). Furthermore, there was a higher mean placental weight, adjusted for gestational age, in the Swedish HELLP material than in the preeclampsia group (P<0.001). Finally, mothers in the preeclampsia group gave birth significantly more often to small for gestational age babies than mothers suffering from HELLP syndrome (P<0.001). The histopathologic profile and the range of placental lesions were partly different in the preeclampsia and HELLP patients. Considering the central role that placenta seems to have in preeclampsia, the present result might suggest that different underlying pathogenetic mechanisms and courses can be in play in patients with preeclampsia and HELLP syndrome.
|
|
| 10. |
- Vinnars, Marie-Therese, et al.
(författare)
-
The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction
- 2010
-
Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - : Nordic Federation of Societies of Obstetrics and Gynecology. - 0001-6349 .- 1600-0412. ; 90:1, s. 19-25
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To correlate placental histopathology, in particular ischemic changes, with the clinical severity of preeclampsia.Design: A blinded retrospective study.Setting: One Swedish hospital.Sample: One hundred and fifty-seven women with severe (n= 116) or mild (n= 41) preeclampsia and 157 normotensive women matched according to gestational-age.Methods: One senior pathologist, blinded to clinical data and group, examined all histological slides. In the statistical analyses, adjustment for gestational week was done when appropriate.Main outcome measures: Placental histopathological findings. Results: Amount of infarction increased with the severity of preeclampsia (p < 0.001). Infarction involving ≥5% of the placental tissue was seen in 39.7% of severe preeclampsia, 17.1% of mild preeclampsia and 5.1% of non-preeclampsia. When comparing placentas in severe preeclampsia, mild preeclampsia and non-preeclampsia, there was an increase in the presence of any infarction (80.2%, 61.0%, vs. 20.4%). Also, there was a difference in the presence of decidual arteriopathy (35.3%, 22.0%, vs. 3.8%) and accelerated villous maturation (71.6%, 53.3%, vs. 12.6%). We found no difference in intervillous thrombosis, abruption placenta or placental weight in relation to gestational week.Conclusions: In pregnancies with mild or severe preeclampsia, a large proportion of the placentas had histological signs of pathology, in particular signs of ischemia. The pathology was similar, but more pronounced in severe compared to mild preeclampsia, suggesting mild and severe preeclampsia to have similar underlying etiology.
|
|
